drugset / Trial / NCT04984317

Feasibility of BOTOX Injection on Improving Female Stress Urinary Incontinence

NCT04984317

Phase 0 Suspended 20 enrolled Northwell Health Allergan · collab
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to assess the effect of onabotulinumtoxin A (BOTOX) injection into the detrusor muscle on increasing bladder compliance to reduce urinary leakage in women suffering from stress urinary incontinence (SUI).

Timeline

Start
2022-02-14
Primary completion
2026-12
Completion
2027-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Botulinum toxin type A Protein / enzyme biologic 100 iu Other